Name: Hereditary Testing Market by Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing); By Technology (Cytogenetic, Biochemical, Molecular Testing); & Region, Global trends and forecast from 2022 to 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (99 reviews)
Author: Exactitude Consultancy
ISBN: 3449

Hereditary Testing Market Overview

The global hereditary testing market size was valued at USD 6 billion in 2020 and is projected to register at a CAGR of 6.4% and expected to reach at USD 10.50 billion in 2029 during the forecast period 2022 to 2029.

In genetic testing, specific inherited variations within an individual's genes undergo alteration. These genetic variations can have varied effects on the likelihood of developing diseases, ranging from negative to positive, neutral, or ambiguous. There is evidence indicating that certain genes with harmful mutations increase the risk of cancer development, accounting for an estimated 5 to 10% of all cancer cases.

Cancer, a genetic disorder, arises from distinct gene alterations that regulate cell functions, particularly influencing their growth and replication. Approximately 5–10% of cancer cases stem from hereditary genetic mutations. Researchers have associated mutations in specific genes with over 50 hereditary cancer syndromes, predisposing individuals to certain types of cancer.

Breast cancer stands as one of the most prevalent cancers globally, affecting nearly 12.5% of women during their lifetime, with 5%–10% having a hereditary form. While BRCA1 and BRCA2 genes are the most commonly mutated, additional genes linked to hereditary breast cancer continue to emerge. Advancements in genomic technologies have enabled simultaneous testing of multiple genes.

[caption id="attachment_3738" align="aligncenter" width="870"]

Hereditary Testing Market | Exactitude Consultancy[/caption]

Genetic mutations play a crucial role in early detection of hereditary cancer, thereby driving market growth. Concurrently, factors such as efficiency and cost-effectiveness compared to traditional testing methods contribute to market expansion. Furthermore, there is increasing demand for accurate initial detection and precise analysis, further propelling market growth.

The burgeoning field of reproductive genetic health serves as a significant market driver. Major players like Natera report a consistent rise in test volumes for women's health genetic testing for inherited conditions, reflecting growing public acceptance of hereditary tests and accelerating revenue growth. However, the COVID-19 pandemic had a detrimental impact on the market, with governments worldwide implementing lockdowns and social distancing measures, leading to disruptions, challenges, and adjustments across industries.

[caption id="attachment_3740" align="aligncenter" width="680"]

Hereditary Testing Market | Exactitude Consultancy[/caption]

Hereditary Testing Market Segment Analysis

Hereditary testing market is broadly classified into disease type, technology and region. Based on disease type, the market is further segmented into hereditary cancer testing and hereditary non-cancer testing. Based on disease type, the cancer hereditary testing category is predicted to grow at fastest rate. The number of product and service options for various hereditary cancer diagnostics continues to expand. The quick introduction of large corporations, such as Quest, into this field has exploded the genetic testing industry. Businesses are concentrating on commercial strategies to strengthen their position in this field, considering breast cancer genomic screening as a lucrative revenue stream.

Based on technology, the molecular hereditary testing category had 54.2 percent of the revenue market share, and this dominance is likely to continue during the forecast period. The fact that genetic analysis is the most extensively used tool for hereditary genetic screening accounts for the market's growth.

Hereditary Testing Market Key Players

Some of the major market players operating in the global hereditary testing market are Agilent Technologies, Inc., Centogene N.V., CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Medgenome, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, Sophia Genetics, Thermo Fisher Scientific, Inc, and Twist Bioscience.

Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek.
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients. CENTOGENE is a world leader in the field of genetic diagnostics for rare diseases dedicated to improve patients' lives every day.
CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics.

Who Should Buy? Or Key stakeholders

Healthcare Industry
Pharmaceutical Industry
Hospitals and Clinics
Medical Laboratories
Investors
Manufacturing companies
Scientific Research and Development
End user companies
Others

Key Takeaways:

The global hereditary testing market size is projected to register at a CAGR of 6.4%
Based on disease type, the cancer hereditary testing category is predicted to grow at fastest rate.
Based on technology, the molecular hereditary testing category had 54.2 percent of the revenue market share.
Europe is predicted to provide the greatest revenue market share.
The hereditary testing market is witnessing a growing trend towards increased adoption and innovation.

Hereditary Testing Market Regional Analysis

The global hereditary testing market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

[caption id="attachment_3742" align="alignnone" width="680"]

Hereditary Testing Market | Exactitude Consultancy[/caption]

Europe is predicted to provide the greatest revenue market share, and this dominance is expected to continue throughout the forecast period. It can be attributed to the existence of large companies that offer genetic tests, the widespread use of modern medications, and government regulations that ensure the integrity of hereditary testing screening. The North American market is expected to account for a major portion of global sales. Numerous regulatory regimes, a high frequency and awareness of the negative impacts and financial significance of genetic disorders, and commercial acceptance of hereditary testing are all factors in the region's growth.

Key Market Segments: Hereditary Testing Market

Hereditary Testing Market By Disease Type, 2020-2029, (USD Million)

Hereditary Cancer Testing
Hereditary Non-Cancer Testing

Hereditary Testing Market By Technology, 2020-2029, (USD MILLION)

Cytogenetic
Biochemical
Molecular Testing

Hereditary Testing Market By Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What are the growth opportunities related to the adoption of hereditary testing across major regions in the future?
What are the new trends and advancements in the hereditary testing market?

Which product categories are expected to have highest growth rate in the hereditary testing market?

Which are the key factors driving the hereditary testing market?
What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations

Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources

Executive Summary

Market Overview
1. Global Hereditary Testing Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Hereditary Testing Market
3. Porter’s five forces model
  1. Threat from new entrants
  2. Threat from substitutes
  3. Bargaining power of suppliers
  4. Bargaining power of customers
  5. Degree of competition
4. Industry value chain Analysis

Global Hereditary Testing Market by Disease Type (USD Million)
1. Hereditary Cancer Testing
2. Hereditary Non-Cancer Testing

Global Hereditary Testing Market by Technology (USD Million)
1. Cytogenetic
2. Biochemical
3. Molecular Testing

Global Hereditary Testing Market by Region (USD Million)
1. North America
  1. US
  2. Canada
  3. Mexico
2. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest Of South America
3. Europe
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest Of Europe
4. Asia Pacific
  1. India
  2. China
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest Of Asia Pacific
5. Middle East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest Of Middle East and Africa

Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
1. Agilent Technologies, Inc.
2. Centogene N.V.
3. CooperSurgical, Inc.
4. Hoffmann-La Roche Ltd
5. Fulgent Genetics, Inc., Illumina, Inc.
6. Invitae Corporation
7. Laboratory Corporation of America Holdings
8. Medgenome
9. Myriad Genetics, Inc.
10. Natera, Inc.

*The Company List Is Indicative

LIST OF TABLES

TABLE 1                GLOBAL HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 2                GLOBAL HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 3                GLOBAL HEREDITARY TESTING MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 4                US HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 5                US HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 6                CANADA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 7                CANADA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 8                MEXICO HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 9                MEXICO HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 10             BRAZIL HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 11             BRAZIL HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 12             ARGENTINA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 13             ARGENTINA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 14             COLOMBIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 15             COLOMBIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 16             REST OF SOUTH AMERICA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 17             REST OF SOUTH AMERICA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 18             INDIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 19             INDIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 20             CHINA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 21             CHINA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 22             JAPAN HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 23             JAPAN HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 24             SOUTH KOREA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 25             SOUTH KOREA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 26             AUSTRALIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 27             AUSTRALIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 28             SOUTH-EAST ASIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 29             SOUTH-EAST ASIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 30             REST OF ASIA PACIFIC HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 31             REST OF ASIA PACIFIC HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 32             GERMANY HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 33             GERMANY HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 34             UK HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 35             UK HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 36             FRANCE HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 37             FRANCE HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 38             ITALY HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 39             ITALY HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 40             SPAIN HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 41             SPAIN HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 42             RUSSIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 43             RUSSIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 44             REST OF EUROPE HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 45             REST OF EUROPE HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 46             UAE HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 47             UAE HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 48             SAUDI ARABIA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 49             SAUDI ARABIA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 50             SOUTH AFRICA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 51             SOUTH AFRICA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 52             REST OF MIDDLE EAST AND AFRICA HEREDITARY TESTING MARKET BY DISEASE TYPE (USD MILLIONS) 2020-2029

TABLE 53             REST OF MIDDLE EAST AND AFRICA HEREDITARY TESTING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1        MARKET DYNAMICS

FIGURE 2        MARKET SEGMENTATION

FIGURE 3        REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4        DATA TRIANGULATION

FIGURE 5        BOTTOM-UP APPROACH

FIGURE 6        TOP-DOWN APPROACH

FIGURE 7        RESEARCH FLOW

FIGURE 8        GLOBAL HEREDITARY TESTING MARKET BY DISEASE TYPE, USD MILLION, 2020-2029

FIGURE 9        GLOBAL HEREDITARY TESTING MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 10      GLOBAL HEREDITARY TESTING MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 11      GLOBAL HEREDITARY TESTING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12      PORTER’S FIVE FORCES MODEL

FIGURE 13      NORTH AMERICA HEREDITARY TESTING MARKET SNAPSHOT

FIGURE 14      EUROPE HEREDITARY TESTING MARKET SNAPSHOT

FIGURE 15      ASIA PACIFIC HEREDITARY TESTING MARKET SNAPSHOT

FIGURE 16      SOUTH AMERICA HEREDITARY TESTING MARKET SNAPSHOT

FIGURE 17      MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SNAPSHOT

FIGURE 18      AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT

FIGURE 19      CENTOGENE N.V.: COMPANY SNAPSHOT

FIGURE 20      COOPERSURGICAL, INC.: COMPANY SNAPSHOT

FIGURE 21      F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT

FIGURE 22      FULGENT GENETICS, INC., ILLUMINA, INC.: COMPANY SNAPSHOT

FIGURE 23      INVITAE CORPORATION: COMPANY SNAPSHOT

FIGURE 24      LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT

FIGURE 25      MEDGENOME: COMPANY SNAPSHOT

FIGURE 26      MYRIAD GENETICS, INC.: COMPANY SNAPSHOT

FIGURE 27      NATERA, INC.: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Hereditary Testing Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period